Singapore: Israel-based Teva Pharmaceuticals has recieved favourable response in England and Wales regarding the validit...
Mumbai: The pharmaceutical industry will be widely impacted after India's National Pharmaceutical Pricing Authority (NPP...
Singapore: Antidepressant market in US, that peaked at USD12 billion in 2008, has lost USD2.6 billion due to expired pat...
Australia's Starpharma Holdings Ltd and Ansell Limited have announced that the Australian Olympic team will be provided ...
Singapore: US based Celgene has settled the litigation with India's Natco Pharma, Natco's US partner, Arrow Internationa...
Singapore: Three quarters of the population of China and India are diabetic. This translates to a patient pool of nearly...
Singapore: According to a research conducted by the National Bureau of Economic Research, some generic drugs sent from I...
The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the ...
The global biologics research and development arm of AstraZeneca, MedImmune LLC, has entered into an exclusive license a...
Singapore: US generics major Mylan has entered into a settlement agreement with OSI Pharmaceuticals, a subsidiary of Jap...
New Delhi: The Indian health ministry has banned the sale of three medicines after learning about the health risks assoc...
Singapore: Beximco Pharmaceuticals, a manufacturer of generic pharmaceutical products and active pharmaceutical ingredie...
Singapore: Glenmark Pharmaceuticals(Glenmark) has been granted final approval by the United States Food & Drug Admin...
Singapore: US-based Amneal pharmaceuticals announced the acquisition of Actavis pharmaceuticals' generic business in Aus...
Singapore: ANI Pharmaceuticals, a global specialty pharmaceutical company recently announced collaboration with IDT Aust...
Brickell Biotech Inc., a US-based clinical-stage pharmaceutical company has signed an exclusive license and development ...
Singapore: Indian drug major Lupin Pharmaceuticals is set to expand its global footprint by scouting for acquisitions ac...
Singapore: US treatment market for rheumatoid arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9...